Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 double-blind trial of intravenous immunoglobulin (GGS) in microscopic polyangiitis with neuropathy
jRCT2080222344Phase 3Completed
- Sponsor
- Teijin Pharma
- Start
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in microscopic polyangiitis (MPA) and peripheral neuropathy comparing GGS (IVIG) + corticosteroid with Placebo + corticosteroid (2 arms). Started Dec 2013; status: completed.
02
Drugs
immune globulin
03
Conditions
microscopic polyangiitis (MPA)peripheral neuropathy
Beyond the preview
Go deeper on jRCT2080222344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222344.